Freeline Therapeutics Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Freeline Therapeutics Holdings generated cash of -$78,224,000, which is more than the previous year. Cash used in financing activities reached the amount of $27,523,000 last year. Net change in cash is therefore -$70,457,000.
Cash Flow
| 2018 | -25.77M | -3.74M | 38.13M |
|---|---|---|---|
| 2019 | -52.32M | -3.02M | 114.58M |
| 2020 | -94.96M | -2.38M | 242.62M |
| 2021 | -107.55M | -4.27M | -984K |
| 2022 | -78.22M | -7.01M | 27.52M |
FRLN Cash Flow Statement (2018 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Cash at beginning of period | 119.06M | 231.57M | 74.57M | 16.34M | 8.54M |
Operating activities | |||||
Net income | -88.97M | -140.39M | -96.32M | -53.90M | -33.28M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 1.74M | 2.39M | 1.91M | 1.54M | 970K |
Stock-based compensation expense | 5.07M | 10.72M | 6.20M | 1.45M | 114K |
| Deferred income tax benefit | 5.07M | 10.72M | 6.20M | 1.45M | 114K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 98K | -91K | 0 | 54K |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 5.44M | -2.89M | 1.54M | 4.13M | 7.52M |
Cash generated by operating activities | -78.22M | -107.55M | -94.96M | -52.32M | -25.77M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -7.01M | -4.27M | -2.51M | -3.02M | -3.74M |
Acquisitions Net | 0 | 0 | 126.98K | 0 | 0 |
Cash generated by investing activities | -7.01M | -4.27M | -2.38M | -3.02M | -3.74M |
Financing activities | |||||
Common Stock Issued | 27.32M | 178.97K | 161.75M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 27.52M | -984K | 242.62M | 114.58M | 38.13M |
Net Change In Cash | -70.45M | -112.51M | 157.00M | 58.23M | 7.8M |
Cash at end of period | 48.60M | 119.06M | 231.57M | 74.57M | 16.34M |
| Data source | Data source | Data source |